Upon ligand-receptor binding, tumor-derived IL-6 plays a crucial role in promoting MDSC chemotaxis within the TIME by activating the JAK/STAT3 and NF-κB signaling pathways [43, 44]. This evidence concerns the gene STAT3 and neoplasm.